The Tohoku Journal of Experimental Medicine
Online ISSN : 1349-3329
Print ISSN : 0040-8727
ISSN-L : 0040-8727
Mass Screening for Neuroblastoma in Miyagi Prefecture
MASAYUKI ITANOSEI MORITAHIROMI FUJIEYOSHIYUKI OHASHINAOKO MINEGISHIMASAYOSHI MINEGISHIYOSHIKO YAMAGUCHITETSUO SATOSHIGERU TSUCHIYATASUKE KONNOYUTAKA HAYASHIRYOJI OHIHIROYUKI SHIRAISHI
Author information
JOURNAL FREE ACCESS

1992 Volume 168 Issue 2 Pages 137-139

Details
Abstract
ITANO, M., MORITA, S., FUJIE, H., OHASHI, Y., MINEGISHI, N., MINEGISHI, M., YAMAGUCHI, Y., SATO, T., TSUCHIYA, S., KONNO, T., HAYASHI, Y., OHI, R. and SHIRAISHI, H. Mass Screening for Neuroblastoma in Miyagi Prefecture. Tohoku J. Exp. Med., 1992, 168 (2), 137-139 - In Japan, aiming at early and preclinical detection of neuroblastoma in infancy a mass screening program for the tumor has been implemented nationwide using urinary tests for catecholamine metabolites, vanillylmandelic acid (VMA) and homovanillic acid (HVA) (Sawada 1990; Sawada et al. 1991). In this report, the results obtained from the screening program in Miyagi Prefecture for the last 6 years are described. The detection rate of neuroblastoma by mass screening was 1:8, 377 among 125, 652 infants tested in Miyagi Prefecture. All but one patients survived after removal of the primary tumor and none or minimal chemotherapy. - neuroblastoma; mass screening; urine VMA; urine HVA
Content from these authors
© Tohoku University Medical Press
Previous article Next article
feedback
Top